Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Fear of recurrence highly prevalent in RCC survivors

Key clinical point: A survey of renal cell carcinoma (RCC) survivors suggests many fear cancer recurrence.

Major finding: More than half (55%) of patients who survived localized RCC said they fear recurrence.

Study details: A survey on distress and fear of cancer recurrence given to 412 survivors of localized RCC.

Disclosures: The study did not receive specific funding. The authors disclosed relationships with many companies, which are listed in the paper.

Citation:

Bergerot CD et al. JCO Oncol Pract. 2020 Nov;16(11):e1264-71.